Company Filing History:
1 out of 4 
1 out of 7 Years Active: 2020
Title: Alexandra Matzke-Ogi: Innovator in Cancer Treatment
Introduction
Alexandra Matzke-Ogi is a prominent inventor based in Eggenstein-Leopoldshafen, Germany. She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic compounds. Her work focuses on utilizing cyclic peptides to address various forms of cancer and related diseases.
Latest Patents
Matzke-Ogi holds a patent for "CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases." This invention encompasses compounds, pharmaceutical compositions, and methods aimed at treating different types of cancer and diseases associated with angiogenesis. The patent highlights her commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout her career, Matzke-Ogi has worked with notable organizations, including Amcure GmbH and Ruprecht-Karls-Universität. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Matzke-Ogi has collaborated with esteemed colleagues such as Véronique Orian-Rousseau and Uwe Haberkorn. These partnerships have further enriched her research and expanded the impact of her work in cancer treatment.
Conclusion
Alexandra Matzke-Ogi is a trailblazer in the field of cancer research, with a focus on innovative treatments using cyclic peptides. Her contributions are paving the way for new therapeutic options and enhancing the fight against cancer.